Cargando…

Quality Improvement Intervention for Reduction of Redundant Testing

Laboratory data are critical to analyzing and improving clinical quality. In the setting of residual use of creatine kinase M and B isoenzyme testing for myocardial infarction, we assessed disease outcomes of discordant creatine kinase M and B isoenzyme +/troponin I (−) test pairs in order to addres...

Descripción completa

Detalles Bibliográficos
Autores principales: Ducatman, Alan M., Tacker, Danyel H., Ducatman, Barbara S., Long, Dustin, Perrotta, Peter L., Lawther, Hannah, Pennington, Kelly, Lander, Owen, Warden, Mary, Failinger, Conard, Halbritter, Kevin, Pellegrino, Ronald, Treese, Marney, Stead, Jeffrey A., Glass, Eric, Cianciaruso, Lauren, Nau, Konrad C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497914/
https://www.ncbi.nlm.nih.gov/pubmed/28725791
http://dx.doi.org/10.1177/2374289517707506
_version_ 1783248215248732160
author Ducatman, Alan M.
Tacker, Danyel H.
Ducatman, Barbara S.
Long, Dustin
Perrotta, Peter L.
Lawther, Hannah
Pennington, Kelly
Lander, Owen
Warden, Mary
Failinger, Conard
Halbritter, Kevin
Pellegrino, Ronald
Treese, Marney
Stead, Jeffrey A.
Glass, Eric
Cianciaruso, Lauren
Nau, Konrad C.
author_facet Ducatman, Alan M.
Tacker, Danyel H.
Ducatman, Barbara S.
Long, Dustin
Perrotta, Peter L.
Lawther, Hannah
Pennington, Kelly
Lander, Owen
Warden, Mary
Failinger, Conard
Halbritter, Kevin
Pellegrino, Ronald
Treese, Marney
Stead, Jeffrey A.
Glass, Eric
Cianciaruso, Lauren
Nau, Konrad C.
author_sort Ducatman, Alan M.
collection PubMed
description Laboratory data are critical to analyzing and improving clinical quality. In the setting of residual use of creatine kinase M and B isoenzyme testing for myocardial infarction, we assessed disease outcomes of discordant creatine kinase M and B isoenzyme +/troponin I (−) test pairs in order to address anticipated clinician concerns about potential loss of case-finding sensitivity following proposed discontinuation of routine creatine kinase and creatine kinase M and B isoenzyme testing. Time-sequenced interventions were introduced. The main outcome was the percentage of cardiac marker studies performed within guidelines. Nonguideline orders dominated at baseline. Creatine kinase M and B isoenzyme testing in 7496 order sets failed to detect additional myocardial infarctions but was associated with 42 potentially preventable admissions/quarter. Interruptive computerized soft stops improved guideline compliance from 32.3% to 58% (P < .001) in services not receiving peer leader intervention and to >80% (P < .001) with peer leadership that featured dashboard feedback about test order performance. This successful experience was recapitulated in interrupted time series within 2 additional services within facility 1 and then in 2 external hospitals (including a critical access facility). Improvements have been sustained postintervention. Laboratory cost savings at the academic facility were estimated to be ≥US$635 000 per year. National collaborative data indicated that facility 1 improved its order patterns from fourth to first quartile compared to peer norms and imply that nonguideline orders persist elsewhere. This example illustrates how pathologists can provide leadership in assisting clinicians in changing laboratory ordering practices. We found that clinicians respond to local laboratory data about their own test performance and that evidence suggesting harm is more compelling to clinicians than evidence of cost savings. Our experience indicates that interventions done at an academic facility can be readily instituted by private practitioners at external facilities. The intervention data also supplement existing literature that electronic order interruptions are more successful when combined with modalities that rely on peer education combined with dashboard feedback about laboratory order performance. The findings may have implications for the role of the pathology laboratory in the ongoing pivot from quantity-based to value-based health care.
format Online
Article
Text
id pubmed-5497914
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-54979142017-07-06 Quality Improvement Intervention for Reduction of Redundant Testing Ducatman, Alan M. Tacker, Danyel H. Ducatman, Barbara S. Long, Dustin Perrotta, Peter L. Lawther, Hannah Pennington, Kelly Lander, Owen Warden, Mary Failinger, Conard Halbritter, Kevin Pellegrino, Ronald Treese, Marney Stead, Jeffrey A. Glass, Eric Cianciaruso, Lauren Nau, Konrad C. Acad Pathol Regular Article Laboratory data are critical to analyzing and improving clinical quality. In the setting of residual use of creatine kinase M and B isoenzyme testing for myocardial infarction, we assessed disease outcomes of discordant creatine kinase M and B isoenzyme +/troponin I (−) test pairs in order to address anticipated clinician concerns about potential loss of case-finding sensitivity following proposed discontinuation of routine creatine kinase and creatine kinase M and B isoenzyme testing. Time-sequenced interventions were introduced. The main outcome was the percentage of cardiac marker studies performed within guidelines. Nonguideline orders dominated at baseline. Creatine kinase M and B isoenzyme testing in 7496 order sets failed to detect additional myocardial infarctions but was associated with 42 potentially preventable admissions/quarter. Interruptive computerized soft stops improved guideline compliance from 32.3% to 58% (P < .001) in services not receiving peer leader intervention and to >80% (P < .001) with peer leadership that featured dashboard feedback about test order performance. This successful experience was recapitulated in interrupted time series within 2 additional services within facility 1 and then in 2 external hospitals (including a critical access facility). Improvements have been sustained postintervention. Laboratory cost savings at the academic facility were estimated to be ≥US$635 000 per year. National collaborative data indicated that facility 1 improved its order patterns from fourth to first quartile compared to peer norms and imply that nonguideline orders persist elsewhere. This example illustrates how pathologists can provide leadership in assisting clinicians in changing laboratory ordering practices. We found that clinicians respond to local laboratory data about their own test performance and that evidence suggesting harm is more compelling to clinicians than evidence of cost savings. Our experience indicates that interventions done at an academic facility can be readily instituted by private practitioners at external facilities. The intervention data also supplement existing literature that electronic order interruptions are more successful when combined with modalities that rely on peer education combined with dashboard feedback about laboratory order performance. The findings may have implications for the role of the pathology laboratory in the ongoing pivot from quantity-based to value-based health care. SAGE Publications 2017-05-28 /pmc/articles/PMC5497914/ /pubmed/28725791 http://dx.doi.org/10.1177/2374289517707506 Text en © The Author(s) 2017 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Regular Article
Ducatman, Alan M.
Tacker, Danyel H.
Ducatman, Barbara S.
Long, Dustin
Perrotta, Peter L.
Lawther, Hannah
Pennington, Kelly
Lander, Owen
Warden, Mary
Failinger, Conard
Halbritter, Kevin
Pellegrino, Ronald
Treese, Marney
Stead, Jeffrey A.
Glass, Eric
Cianciaruso, Lauren
Nau, Konrad C.
Quality Improvement Intervention for Reduction of Redundant Testing
title Quality Improvement Intervention for Reduction of Redundant Testing
title_full Quality Improvement Intervention for Reduction of Redundant Testing
title_fullStr Quality Improvement Intervention for Reduction of Redundant Testing
title_full_unstemmed Quality Improvement Intervention for Reduction of Redundant Testing
title_short Quality Improvement Intervention for Reduction of Redundant Testing
title_sort quality improvement intervention for reduction of redundant testing
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497914/
https://www.ncbi.nlm.nih.gov/pubmed/28725791
http://dx.doi.org/10.1177/2374289517707506
work_keys_str_mv AT ducatmanalanm qualityimprovementinterventionforreductionofredundanttesting
AT tackerdanyelh qualityimprovementinterventionforreductionofredundanttesting
AT ducatmanbarbaras qualityimprovementinterventionforreductionofredundanttesting
AT longdustin qualityimprovementinterventionforreductionofredundanttesting
AT perrottapeterl qualityimprovementinterventionforreductionofredundanttesting
AT lawtherhannah qualityimprovementinterventionforreductionofredundanttesting
AT penningtonkelly qualityimprovementinterventionforreductionofredundanttesting
AT landerowen qualityimprovementinterventionforreductionofredundanttesting
AT wardenmary qualityimprovementinterventionforreductionofredundanttesting
AT failingerconard qualityimprovementinterventionforreductionofredundanttesting
AT halbritterkevin qualityimprovementinterventionforreductionofredundanttesting
AT pellegrinoronald qualityimprovementinterventionforreductionofredundanttesting
AT treesemarney qualityimprovementinterventionforreductionofredundanttesting
AT steadjeffreya qualityimprovementinterventionforreductionofredundanttesting
AT glasseric qualityimprovementinterventionforreductionofredundanttesting
AT cianciarusolauren qualityimprovementinterventionforreductionofredundanttesting
AT naukonradc qualityimprovementinterventionforreductionofredundanttesting